High-Density lipoprotein assay device and method
First Claim
Patent Images
1. An assay device for measuring serum cholesterol associated with high-density lipoproteins (HDL) in a blood fluid sample also containing low density lipoproteins (LDL) or very low density lipoproteins (VLDL), the device comprising:
- (i) a plurality of porous elements through which said blood fluid sample can flow in sequence by capillary action and/or gravity, said plurality comprising;
a sample distribution matrix;
an HDL test pad, downstream of said matrix, in which HDL concentration can be assayed; and
, upstream of said HDL test pad, an element containing an immobilized reagent effective to selectively bind and remove non-HDL lipoproteins from the fluid sample; and
(ii) mounting means effective to adjust the device between (a) a sample-distribution position, wherein the HDL test pad is not in fluid communication with the sample distribution matrix, and (b) a test position, wherein said test pad and distribution matrix are in fluid communication with each other.
9 Assignments
0 Petitions
Accused Products
Abstract
An assay device and method for measuring the concentration of HDL-associated cholesterol in a blood-fluid sample are described. The assay design prevents interference by reagents used for such removal with the HDL quantification reaction or with other assays carried out on the same sample. If desired, removal of non-HDL lipoproteins and assay of HDL cholesterol can be carried out without interruption of the assay.
-
Citations
25 Claims
-
1. An assay device for measuring serum cholesterol associated with high-density lipoproteins (HDL) in a blood fluid sample also containing low density lipoproteins (LDL) or very low density lipoproteins (VLDL), the device comprising:
-
(i) a plurality of porous elements through which said blood fluid sample can flow in sequence by capillary action and/or gravity, said plurality comprising;
a sample distribution matrix;
an HDL test pad, downstream of said matrix, in which HDL concentration can be assayed; and
, upstream of said HDL test pad, an element containing an immobilized reagent effective to selectively bind and remove non-HDL lipoproteins from the fluid sample; and
(ii) mounting means effective to adjust the device between (a) a sample-distribution position, wherein the HDL test pad is not in fluid communication with the sample distribution matrix, and (b) a test position, wherein said test pad and distribution matrix are in fluid communication with each other. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)
-
-
15. An assay device for measuring serum cholesterol associated with high-density lipoproteins (HDL) in a blood fluid sample also containing low density lipoproteins (LDL) or very low density lipoproteins (VLDL), the device comprising:
-
a sample distribution matrix for distributing the blood fluid sample;
a reagent pad containing an immobilized reagent effective to selectively remove non-HDL lipoproteins from the fluid sample; and
a HDL test pad in which HDL concentration can be assayed, in fluid communication with said reagent pad;
wherein said reagent pad may be brought into fluid communication with said sample matrix. - View Dependent Claims (16)
-
-
17. A method of measuring serum cholesterol associated with high-density lipoproteins (HDL) in a blood fluid sample also containing low density lipoproteins (LDL) or very low density lipoproteins (VLDL), comprising
(a) contacting the sample with an absorptive sample distribution matrix, wherein said sample distribution matrix is one of a plurality of porous elements contained within an assay device, through which said blood fluid sample can flow in sequence by capillary action and/or gravity, said plurality of elements further including: - an HDL test pad, downstream of the sample distribution matrix, in which HDL concentration can be assayed; and
, upstream of said HDL test pad, an element containing an immobilized reagent effective to selectively bind and remove non-HDL lipoproteins from the fluid sample;
(b) contacting said sample with said element containing said immobilized reagent;
(c) placing said matrix in fluid communication with said HDL test pad, whereby said sample is transferred from said element to said HDL test pad; and
(d) determining the content of HDL lipoproteins in said blood fluid sample;
wherein, prior to step (c), said matrix is not in fluid communication with said HDL test pad. - View Dependent Claims (18, 19, 20, 21, 22, 23, 24, 25)
- an HDL test pad, downstream of the sample distribution matrix, in which HDL concentration can be assayed; and
Specification